A recent survey by the health policy nonprofit KFF reveals that 1 in 8 American adults have tried GLP-1 drugs, with half of them currently using it. The study shows that GLP-1 treatment is popular among diabetic, heart disease, and overweight individuals. However, over half of the respondents find it difficult to afford, especially for older adults. The survey also indicates a growing awareness of GLP-1 drugs among adults, with many supporting Medicare coverage for overweight individuals prescribed for weight loss.
1 In 8 US Adults Have Tried GLP-1 Obesity Medications, Poll Finds https://t.co/puIiGUzt26
Our latest AI generated analysis reveals interesting insights into the GLP-1 market, poised to reach $100 billion in the US by 2030. 📈 With an estimated 30 million users by 2030, GLP-1 drugs are revolutionizing diabetes care and weight management. Key Highlights: 🏥 19%… https://t.co/sDoT8szyiG
KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs 1) 45% willing to try GLP1, but only 23% would try if subQ & only 16% would try if insurance didn't cover 2) 80% think insurance should cover GLP1 for overweight/obese pts, 3) 73% believe there…
About 6 in 10 adults say that Medicare should cover GLP-1 drugs for people who are overweight when they’re prescribed for weight loss. This includes similar shares across age groups, and more than half of Democrats, independents, and Republicans. https://t.co/SQ6smpzrQj https://t.co/qnGLiPS5q9
Awareness of GLP-1 drugs is on the rise, with 8 in 10 adults reporting they’ve at least heard “a little” about them. About one-third of adults have heard “a lot” about GLP-1 medications. Dive into more data with our tracking poll: https://t.co/SQ6smpzrQj https://t.co/WDHb2Qz3jO
A new poll from the health policy nonprofit KFF found that one in eight adults say they’ve taken a GLP-1 agonist, the obesity and diabetes medications that include Ozempic, Mounjaro and Zepbound. https://t.co/HzceRoPKaj
More than half of those surveyed, 54%, said it was difficult to afford, with 22% saying it was very difficult, according to KFF. For people 65 and older, 8% had taken a GLP-1 drug for a medical condition, with just 1% for weight loss. https://t.co/bcLu8x8Jev
Nearly half of all diabetic respondents, 43%, had gotten GLP-1 treatment, while 25% with heart disease and 22% of those overweight had taken such a drug. https://t.co/bcLu8x8Jev
The study surveyed 1,479 people from April 23 through May 1. Among respondents, 12% had taken a GLP-1 drug at some point, with 6% currently taking it. https://t.co/bcLu8x8Jev
My friend @chigrl made fun of this post. Well done. It's a classic example of how to think critically. The survey data indicates 1/8 American have tried GLP-1's and half of those are using it. That's 15MN people taking a drug that the article says cost $1000 per month. Okay…